Tag: $Abbott Laboratories

Abbott Laboratories shares rose nearly 5% before the bell on Friday, after a jury cleared the company and a Reckitt unit of liability in a lawsuit over their premature baby formulas’ risks.

The maker of healthcare products posted adjusted earnings of $1.21 per share for the third quarter, topping Wall Street’s call for $1.20, according to FactSet.

Abbott Laboratories shares were falling ahead of the opening bell on Monday after a jury found the company had failed to warn that its premature baby formula could increase infants’ risk of developing a potentially deadly bowel illness.